www.biotech66.com

65% Success Rate • 3.9 Profit Factor • 57.58% CAGR Verified Track Record (32-Month Phase)

• Verified Portfolio: Immediate access to our 20-equity biotech matrix.
• Ongoing Updates: 5 to 10 dashboard publications monthly, delivered ex-post upon rebalancing.
• Billing Architecture: $66.00 / month. Cancel anytime.

NO Financial Advice • NO Guarantees • YES Pure Data

Strictly non-advisory independent financial publishing by BioTech 66 Pathways, LLC. Impersonal research only. Past performance does not guarantee future results.